Peptide Bioavailability

Peptide Bioavailability is the fraction and rate at which an administered peptide reaches its site of action in the systemic circulation or target tissue, distinguishing it from other pharmacokinetic parameters by specifically quantifying the therapeutically available portion of the peptide following delivery.

38

Publications

2.5K

Citations

213

Authors

74

Institutions

Publications per year

2017–2026

14

Authors

213

  1. MK
    Monika Karaś

    University of Life Sciences in Lublin, Poland

    2 publications · 108 citations

    2

    h-index

  2. JP
    James P. Gilligan

    Medigene (Germany), Germany

    2 publications · 103 citations

    2

    h-index

  3. EW
    Erik Wagner

    Princeton University, United States

    2 publications · 103 citations

    2

    h-index

  4. LM
    L.T. McWhorter

    University of Colorado Boulder, United States

    2 publications · 103 citations

    2

    h-index

  5. PJ
    Patrick J. Sinko

    Rutgers, The State University of New Jersey, United States

    2 publications · 103 citations

    2

    h-index

1–5 of 213

Venues

  1. Pharmaceutical Research

    4 publications · 158 citations

    4

    h-index

  2. Journal of Pharmaceutical Sciences

    3 publications · 248 citations

    3

    h-index

  3. Journal of Functional Foods

    2 publications · 311 citations

    2

    h-index

  4. Journal of Controlled Release

    2 publications · 93 citations

    2

    h-index

  5. PubMed

    Repository · 2 publications · 225 citations

    2

    h-index

1–5